Heyu Biological Technology Corporation reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported net loss was USD 0.001516 million compared to net income of USD 0.008661 million a year ago.
For the nine months, sales was USD 0.028968 million compared to USD 0.078397 million a year ago. Net loss was USD 0.144376 million compared to USD 0.140938 million a year ago.